Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vascular Access Patency”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Large-scale testing (Phase 3)Study completedNCT04687137
What this trial is testing

Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 12
Not applicableUnknownNCT06034717
What this trial is testing

Primary Patency in Pediatric Patients With Hemodialysis Access

Who this might be right for
The Aim of This Study is to Follow up Short Term "3-6 Months"& Mid Term" 6-12months "Outcomes of Vascular Access" Native and Synthetic "in ESRD Pediatrics
Alaa Gameil Abd El-salam Hussien 60
Not applicableLooking for participantsNCT07383870
What this trial is testing

Clinical Evaluation of an AI- and Ultrasound-Assisted Venipuncture Device

Who this might be right for
Venipuncture
Seoul National University Hospital 190
Post-approval studies (Phase 4)Active Not RecruitingNCT07259772
What this trial is testing

Anesthetic Effect of Ropivacaine on Local Infiltration Anesthesia in Arteriovenous Fistula Surgery

Who this might be right for
End Stage Renal Disease (ESRD)Arteriovenous Fistula PatencyChronic Kidney Disease 5D
The First People's Hospital of Lianyungang 40
Not applicableApproved For MarketingNCT02477891
What this trial is testing

Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC
Not applicableNo Longer AvailableNCT00720603
What this trial is testing

This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma
Genzyme, a Sanofi Company
Large-scale testing (Phase 3)Ended earlyNCT00895479
What this trial is testing

Adenovirus Vascular Endothelial Growth Factor (VEGF) Therapy in Vascular Access - Novel Trinam AGainst Control Evidence

Who this might be right for
End Stage Renal Disease
Ark Therapeutics Ltd 250
Not applicableStudy completedNCT00890045
What this trial is testing

Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study

Who this might be right for
Renal Failure Chronic Requiring Hemodialysis
Merit Medical Systems, Inc. 72
Not applicableStudy completedNCT01335984
What this trial is testing

Effects of Telemonitoring and Telemedicine Service for Hypertensive Care

Who this might be right for
Hypertension
Chang Hee, Lee 440
Not applicableUnknownNCT04861389
What this trial is testing

Distal Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients

Who this might be right for
Acute ST-segment Elevation Myocardial InfarctionRadial Artery OcclusionDistal Radial Artery Approach
Shenzhen People's Hospital 414
Not applicableUnknownNCT05165797
What this trial is testing

Platelet Activation Affecting the Rate of Vascular Access Patency

Who this might be right for
Platelet ActivationHemodialysis Fistula Thrombosis
Korea University Anam Hospital 30
Large-scale testing (Phase 3)Study completedNCT02414841
What this trial is testing

Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)

Who this might be right for
Chronic Kidney Disease
Proteon Therapeutics 696
Not applicableLooking for participantsNCT05644314
What this trial is testing

Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis

Who this might be right for
Ischemic StrokeVertebral Artery Stenosis
Nanfang Hospital, Southern Medical University 144
Testing effectiveness (Phase 2)Study completedNCT02348528
What this trial is testing

Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Who Participated in CC-5013-MM021 for at Least 1 Year

Who this might be right for
Multiple Myeloma
Celgene 65
Large-scale testing (Phase 3)Study completedNCT00669851
What this trial is testing

Acquiring Consensus for Contrast Echocardiography System Settings - ACCESS Study

Who this might be right for
Coronary Artery Disease
Acusphere 39
Not applicableActive Not RecruitingNCT06451185
What this trial is testing

Statseal® for Central Venous Catheter Insertion Sites in Critical Care

Who this might be right for
Central LineCentral Venous CatheterVascular Access+2 more
Liverpool Heart and Chest Hospital NHS Foundation Trust 450
Large-scale testing (Phase 3)Study completedNCT02036255
What this trial is testing

Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase

Who this might be right for
PatencyInfection
Universitair Ziekenhuis Brussel 68
Testing effectiveness (Phase 2)Study completedNCT02335099
What this trial is testing

Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis

Who this might be right for
End Stage Renal DiseaseVascular Access Patency
University of Virginia 54
Post-approval studies (Phase 4)Looking for participantsNCT06057402
What this trial is testing

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Pfizer 80
Large-scale testing (Phase 3)Study completedNCT02565953
What this trial is testing

Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon

Who this might be right for
Arteriovenous Fistula Renal Dialysis Devices Obstruction
Fundación Pública Andaluza Progreso y Salud 134
Load More Results